IU Simon Cancer Center breast cancer specialist named to Susan G. Komen for the Cure board

INDIANAPOLIS -- (Oct. 16, 2007) -- An Indiana University Melvin and Bren Simon Cancer Center breast cancer specialist has been named to a Susan G. Komen for the Cure advisory board.

Dr. George W. Sledge, Ballve-Lantero Professor of Oncology and co-director of the breast cancer program at IU Simon Cancer Center, recently was named to the new Scientific Advisory Board with Komen for his demonstrated leadership and insight into breast cancer research and clinical work along with others from such leading institutions as Johns Hopkins University School of Medicine, University of Texas M.D. Anderson Cancer Center, and Duke Comprehensive Cancer Center.

Sledge also is professor of medicine and pathology at Indiana University School of Medicine.

Komen announced the formation of the advisory board as part of its goal to invest another $1 billion over the next decade toward energizing the scientific community to discover and deliver the cures for breast cancer more quickly.

The board helped design new research grant awards that will focus on bringing recent laboratory advances to the clinic. These new grants will be instrumental in developing new treatments, with the goal of decreasing the number of deaths from breast cancer and, ultimately, preventing the disease. These new awards and the critical upgrades Komen has made to enhance its grants application process will ensure that the $1 billion in breast cancer research and community outreach programs that Komen invests in the next decade will have the greatest possible impact.

“Our Scientific Advisory Board, under the direction of Dr. Eric P. Winer, Komen’s new chief scientific advisor, is a ‘dream team’ of leading breast cancer experts who will continue to advise and guide us in our grant-making efforts,” Hala Moddelmog, Susan G. Komen for the Cure president and CEO, said.